Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep model

Biomaterials

Volumn 31, Issue 14, 2010, Pages 3910-3919

  Hosper, Nynke A ^a   Eggink, Alex J ^b   Roelofs, Luc A J ^b   Wijnen, Rene M H ^b   van Luyn, Marja J A ^a   Bank, Ruud A ^a   Harmsen, Martin C ^a   Geutjes, Paul J ^b   Daamen, Willeke F ^b   van Kuppevelt, Toin H ^b   Tiemessen, Dorien M ^b   Oosterwijk, Egbert ^b   Crevels, Jane J ^a   Blokx, Willeke A M ^b   Lotgering, Fred K ^b   van den Berg, Paul P ^a   Feitz, Wout F J ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Basic fibroblast growth factor; Collagen scaffold; Fetal wound healing; Intra uterine repair; Spina bifida; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN SCAFFOLDS; FETAL WOUND HEALING; VASCULAR ENDOTHELIAL GROWTH FACTOR; WOUND HEALING;

BIOACTIVITY; CELL CULTURE; COLLAGEN; DEFECTS; FIBROBLASTS; NEUROLOGY; PEPTIDES; REPAIR; SELF ASSEMBLY; TISSUE ENGINEERING; WOOL;

SCAFFOLDS;

COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 2; TISSUE SCAFFOLD; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CELL GROWTH; EPITHELIZATION; EXTRACELLULAR MATRIX; FEMALE; FULL THICKNESS SKIN GRAFT; IMMUNOHISTOCHEMISTRY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SCANNING ELECTRON MICROSCOPY; SHEEP; SKIN DEFECT; SURVIVAL RATE; TISSUE ENGINEERING; VASCULARIZATION; WOUND HEALING;

ANIMALS; CATTLE; EPITHELIUM; FEMALE; FETUS; FIBROBLASTS; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY; SHEEP; SKIN; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UTERUS; WOUND HEALING;

OVIS ARIES;

EID: 77649270172     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.01.129     Document Type: Article

References (29)

1. Heffez D.S., Aryanpur J., Hutchins G.M., and Freeman J.M. The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26 (1990) 987-992
2. Bullard K.M., Longaker M.T., and Lorenz H.P. Fetal wound healing: current biology. World J Surg 27 (2003) 54-61
3. Cass D.L., Bullard K.M., Sylvester K.G., Yang E.Y., Longaker M.T., and Adzick N.S. Wound size and gestational age modulate scar formation in fetal wound repair. J Pediatr Surg 32 (1997) 411-415
4. Daamen W.F., Nillesen S.T.M., Hafmans T., Veerkamp J.H., van Luyn M.J.A., and van Kuppevelt T.H. Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 26 (2005) 81-92
5. Eggink A.J., Roelofs L.A., Feitz W.F., Wijnen R.M., Mullaart R.A., Grotenhuis J.A., et al. In utero repair of an experimental neural tube defect in a chronic sheep model using biomatrices. Fetal Diagn Ther 20 (2005) 335-340
6. Eggink A.J., Roelofs L.A., Lammens M.M., Feitz W.F., Wijnen R.M., Mullaart R.A., et al. Histological evaluation of acute covering of an experimental neural tube defect with biomatrices in fetal sheep. Fetal Diagn Ther 21 (2006) 210-216
7. Eggink A.J., Roelofs L.A., Feitz W.F., Wijnen R.M., Lammens M.M., Mullaart R.A., et al. Delayed intrauterine repair of an experimental spina bifida with a collagen biomatrix. Pediatr Neurosurg 44 (2008) 29-35
8. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11 (2000) 617-624
9. Pepper M.S., Ferrara N., Orci L., and Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189 (1992) 824-831
10. Asahara T., Bauters C., Zheng L.P., Takeshita S., Bunting S., Ferrara N., et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92 (1995) II365-II371
11. Lee K.Y., Peters M.C., and Mooney D.J. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 87 (2003) 49-56
12. Nillesen S.T.M., Geutjes P.J., Wismans R., Schalkwijk J., Daamen W.F., and van Kuppevelt T.H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28 (2007) 1123-1131
13. Ono I., Akasaka Y., Kikuchi R., Sakemoto A., Kamiya T., Yamashita T., et al. Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 15 (2007) 617-623
14. Ono I., Tateshita T., and Inoue M. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction. J Biomed Mater Res 48 (1999) 621-630
15. Hebda P.A., Klingbeil C.K., Abraham J.A., and Fiddes J.C. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 95 (1990) 626-631
16. Sogabe Y., Abe M., Yokoyama Y., and Ishikawa O. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen 14 (2006) 457-462
17. Geutjes P.J., Daamen W.F., Buma P., Feitz W.F., Faraj K.A., and van Kuppevelt T.H. From molecules to matrix: construction and evaluation of molecularly defined bioscaffolds. Adv Exp Med Biol 585 (2006) 279-295
18. Pieper J.S., Oosterhof A., Dijkstra P.J., Veerkamp J.H., and van Kuppevelt T.H. Preparation and characterization of porous cross-linked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20 (1999) 847-858
19. Gilbert D.L., and Kim S.W. Macromolecular release from collagen monolithic devices. J Biomed Mater Res 24 (1990) 1221-1239
20. Olde Damink L.H.H., Dijkstra P.J., van Luyn M.J.A., van Wachem P.B., Nieuwenhuis P., and Feijen J. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17 (1996) 765-773
21. Elson L.A., and Morgan W.T. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 27 (1933) 1824-1828
22. Yannas I.V., Burke J.F., Gordon P.L., Huang C., and Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14 (1980) 107-132
23. Smits N.C., Robbesom A.A., Versteeg E.M.M., van de Westerlo E.M.A., Dekhuijzen P.N.R., and van Kuppevelt T.H. Heterogeneity of heparan sulfates in human lung. Am J Respir Cell Mol Biol 30 (2004) 166-173
24. van Kuppevelt T.H., Dennissen M.A., van Venrooij W.J., Hoet R.M., and Veerkamp J.H. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 273 (1998) 12960-12966
25. Kunisaki S.M., Armant M., Kao G.S., Stevenson K., Kim H., and Fauza D.O. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 42 (2007) 974-979
26. Maltseva O., Folger P., Zekaria D., Petridou S., and Masur S.K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol Vis Sci 42 (2001) 2490-2495
27. Ishiguro S., Akasaka Y., Kiguchi H., Suzuki T., Imaizumi R., Ishikawa Y., et al. Basic fibroblast growth factor induces down-regulation of alpha-smooth muscle actin and reduction of myofibroblast areas in open skin wounds. Wound Repair Regen 17 (2009) 617-625
28. Wilgus T.A., Matthies A.M., Radek K.A., Dovi J.V., Burns A.L., Shankar R., et al. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 167 (2005) 1257-1266
29. Brem H., Kodra A., Golinko M.S., Entero H., Stojadinovic O., Wang V.M., et al. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J Invest Dermatol 129 (2009) 2275-2287